A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Thrombocytosis due to clozapine treatment: working towards an early marker for clozapine-induced agranulocytosis
2000
British Journal of Psychiatry
Recently, Hampson (2000) reported thrombocytosis with clozapine, and serious consideration must be given to reports that identify potential markers for the development of agranulocytosis. Haematological side-effects include leucopenia, neutropenia and thrombocytopenia (1–3% of patients); and anaemia, leucocytosis and thrombocytosis (< 1% of patients) (American Hospital Formulary Service, 1997). Thrombocytosis reported with clozapine treatment may give evidence of the mechanism of agranulocytosis in some patients.
doi:10.1192/bjp.177.4.372-b
pmid:11116788
fatcat:cbvktufh6vembiddzfkxslutba